Answer
Women of childbearing potential must use effective contraception throughout dostarlimab treatment and until 4 months after the last dose.
Sources for this answer
- JEMPERLI 500 mg concentrate for solution for infusionGlaxoSmithKline UK · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 14Document updated
Sources checked